BCRX
Price
$7.96
Change
-$0.18 (-2.21%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
1.67B
2 days until earnings call
BDRX
Price
$6.70
Change
-$1.15 (-14.65%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
3.38M
Interact to see
Advertisement

BCRX vs BDRX

Header iconBCRX vs BDRX Comparison
Open Charts BCRX vs BDRXBanner chart's image
BioCryst Pharmaceuticals
Price$7.96
Change-$0.18 (-2.21%)
Volume$191.59K
Capitalization1.67B
Biodexa Pharmaceuticals
Price$6.70
Change-$1.15 (-14.65%)
Volume$310
Capitalization3.38M
BCRX vs BDRX Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 213.98B. NONOF holds the highest valuation in this group at 213.98B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 37%. SLXN experienced the highest price growth at 1,575%, while ADAP experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was 123%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)

Notable companies

The most notable companies in this group are BioCryst Pharmaceuticals (NASDAQ:BCRX).

Market Cap

The average market capitalization across the group is 873.46M. The market cap for tickers in the group ranges from 43.62M to 1.7B. BCRX holds the highest valuation in this group at 1.7B. The lowest valued company is BDRX at 43.62M.

High and low price notable news

The average weekly price growth across all stocks in the group was -8%. For the same group, the average monthly price growth was -10%, and the average quarterly price growth was -40%. BCRX experienced the highest price growth at -5%, while BDRX experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the group was 419%. For the same stocks of the group, the average monthly volume growth was 220% and the average quarterly volume growth was 18,887%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 96
Price Growth Rating: 77
SMR Rating: 98
Profit Risk Rating: 90
Seasonality Score: 0 (-100 ... +100)
VS
BCRX vs. BDRX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and BDRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (BCRX: $8.14 vs. BDRX: $7.85)
Brand notoriety: BCRX: Notable vs. BDRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 156% vs. BDRX: 47%
Market capitalization -- BCRX: $1.67B vs. BDRX: $3.38M
BCRX [@Biotechnology] is valued at $1.67B. BDRX’s [@Biotechnology] market capitalization is $3.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileBDRX’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • BDRX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 3 TA indicator(s) are bullish while BDRX’s TA Score has 5 bullish TA indicator(s).

  • BCRX’s TA Score: 3 bullish, 4 bearish.
  • BDRX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than BCRX.

Price Growth

BCRX (@Biotechnology) experienced а -4.80% price change this week, while BDRX (@Biotechnology) price change was -11.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

BCRX is expected to report earnings on Oct 29, 2025.

BDRX is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.67B) has a higher market cap than BDRX($3.38M). BCRX YTD gains are higher at: 8.245 vs. BDRX (-80.617). BCRX has higher annual earnings (EBITDA): 47.6M vs. BDRX (-5.56M). BCRX has higher revenues than BDRX: BCRX (503M) vs BDRX (0).
BCRXBDRXBCRX / BDRX
Capitalization1.67B3.38M49,232%
EBITDA47.6M-5.56M-856%
Gain YTD8.245-80.617-10%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295MN/A-
Total Debt795MN/A-
FUNDAMENTALS RATINGS
BCRX vs BDRX: Fundamental Ratings
BCRX
BDRX
OUTLOOK RATING
1..100
5924
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6094
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (33) in the Biotechnology industry is in the same range as BDRX (44). This means that BCRX’s stock grew similarly to BDRX’s over the last 12 months.

BCRX's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as BDRX (100). This means that BCRX’s stock grew similarly to BDRX’s over the last 12 months.

BDRX's SMR Rating (97) in the Biotechnology industry is in the same range as BCRX (100). This means that BDRX’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for BDRX (94). This means that BCRX’s stock grew somewhat faster than BDRX’s over the last 12 months.

BDRX's P/E Growth Rating (93) in the Biotechnology industry is in the same range as BCRX (100). This means that BDRX’s stock grew similarly to BCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXBDRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEQX98.68N/A
N/A
Green Century Equity Individual Investor
PSPJX30.34N/A
N/A
Principal Large Cap S&P 500 Index J
FIMPX37.04N/A
N/A
Nuveen Small Cap Growth Opp I
DGYGX39.98N/A
N/A
BNY Mellon Appreciation Y
WCFOX12.30N/A
N/A
WCM Focused International Opps Inv

BCRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-0.97%
VCYT - BCRX
46%
Loosely correlated
-1.92%
CRNX - BCRX
40%
Loosely correlated
-2.26%
CLDX - BCRX
40%
Loosely correlated
-3.64%
ROIV - BCRX
38%
Loosely correlated
-0.26%
BEAM - BCRX
38%
Loosely correlated
-2.23%
More

BDRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-9.11%
LVTX - BDRX
41%
Loosely correlated
+7.04%
ATNF - BDRX
38%
Loosely correlated
-7.54%
KRRO - BDRX
33%
Loosely correlated
-7.66%
SCNI - BDRX
32%
Poorly correlated
-8.82%
AVTX - BDRX
32%
Poorly correlated
+18.47%
More